索拉非尼联合局部治疗在晚期肝癌中的研究进展(4)
[12] Chao Y，Chung YH，Han G，et al. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma：final results of the START trial [J]. Int J Cancer，2015，136(6)：1458-1467.[13] Lencioni R，Llovet JM，Han G ......
您现在查看是摘要页，全文长 2690 字符。